It has been observed that Cdk11 is ubiquitously expressed in human cancer cell lines, and it has been found to be a positive modulator of Wnt/β-catenin pathway in colon cancer (Zhou et al., 2016). Here, CDK11B is linked to malignant colon neoplasm.